Researcher
Jo Caers
- Research Expertise:
- Basic & translational research
- Keywords:Medicine
- Disciplines:Humanities and the arts, Engineering and technology, Natural sciences
- Users of research expertise:
- Basic & translational research
Affiliations
- Hematology (Research group)
Member
From1 Jan 2004 → 30 Sep 2009 - Immunology and Microbiology (Department)
Member
From1 Oct 2003 → 30 Sep 2007
Publications
1 - 10 of 10
- Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pages: 20476-20489 - Molecular mechanisms, current management and next generation therapy in myeloma bone disease(2018)
Authors: Roy Heusschen, Joséphine Muller, Elodie Duray, Nadia Withofs, Arnold Bolomsky, Frédéric Baron, Yves Beguin, Eline Menu, Heinz Ludwig, Jo Caers
Pages: 14-28 - SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma(2016)
Authors: Roy Heusschen, Joséphine Muller, Marilene Binsfeld, Caroline Marty, Erwan Plougonven, Sophie Dubois, Nadia Mahli, Karen Moermans, Geert Carmeliet, Angélique Léonard, et al.
Pages: 30712-30729 - The Effects of Forodesine in Murine and Human Multiple Myeloma Cells(2010)
Authors: Liesbeth Bieghs, Jo Caers, E Van Valckenborgh, Foina Higginbotham
Pages: 1-8 - The Belgian 2010 consensus recommendations for the treatment of Multiple Myeloma(2010)
Authors: M. Delforge, M. Andre, G. Bries, Jo Caers, H. Demuynck, B. De Prijck, H. De Samblanx, A. Kentos, N. Meuleman, Fritz Offner, et al.
Pages: 252-264 - Thymosin β4 in multiple myeloma: friend or foe(2010)
Authors: Jo Caers, Eleonore Otjacques, D. Hose, Bernard Klein
Pages: 125-129 - Thymosin {beta}4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.(2010)
Authors: Jo Caers, D. Hose, Ine Kuipers, Tomas Bos, E Van Valckenborgh, Eline Menu, Elke De Bruyne, Hartmut Goldschmidt, Benjamin Van Camp, Bernard Klein, et al.
Pages: 163-167 - Multiple Myeloma, an update on diagnosis and treatment(2008)
Authors: Jo Caers, Isabelle Vande Broek, L Michaux, Fabienne Trullemans, Benjamin Van Camp
Pages: 329-343 - Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma(2008)
Authors: Jo Caers, Doreen Lepage, E Van Valckenborgh, Benjamin Van Camp, Enrique Alvarez
Pages: 1966-1974 - Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding microenvironment.(2008)
Authors: Jo Caers, E Van Valckenborgh, Benjamin Van Camp
Pages: 301-313